# Salvage Therapy With Sunitinib,Docetaxel and Platinum on Metastatic or Unresectable Non Small Cell Lung Cancer

> **NCT01019798** · PHASE2 · UNKNOWN · sponsor: **Taipei Medical University Hospital** · enrollment: 16 (estimated)

## Conditions studied

- Non Small Cell Lung Cancer

## Interventions

- **DRUG:** sunitinib, docetaxel, cisplatin

## Key facts

- **NCT ID:** NCT01019798
- **Lead sponsor:** Taipei Medical University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2009-01
- **Primary completion:** 2010-12
- **Final completion:** 2011-12
- **Target enrollment:** 16 (ESTIMATED)
- **Last updated:** 2009-11-25

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01019798

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01019798, "Salvage Therapy With Sunitinib,Docetaxel and Platinum on Metastatic or Unresectable Non Small Cell Lung Cancer". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT01019798. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*